Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease

• Published in: JAMA neurology Vol. 70; no. 3; p. 320
• Main Authors: Protas, Hillary D, Chen, Kewei, Langbaum, Jessica B S, Fleisher, Adam S, Alexander, Gene E, Lee, Wendy, Bandy, Daniel, de Leon, Mony J, Mosconi, Lisa, Buckley, Shannon, Truran-Sacrey, Diana, Schuff, Norbert, Weiner, Michael W, Caselli, Richard J, Reiman, Eric M
• Format: Journal Article
• Language: English
• Published: United States 01.03.2013
• Subjects: Aged; Alzheimer Disease - genetics; Alzheimer Disease - metabolism; Alzheimer Disease - pathology; Cognition - physiology; Cohort Studies; Female; Genetic Predisposition to Disease - genetics; Glucose - metabolism; Gyrus Cinguli - metabolism; Hippocampus - metabolism; Hippocampus - pathology; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Organ Size; Risk
• DOI: 10.1001/2013.jamaneurol.286

To characterize and compare measurements of the posterior cingulate glucose metabolism, the hippocampal glucose metabolism, and hippocampal volume so as to distinguish cognitively normal, late-middle-aged persons with 2, 1, or 0 copies of the apolipoprotein E (APOE) ε4 allele, reflecting 3 levels of risk for late-onset Alzheimer disease. Cross-sectional comparison of measurements of cerebral glucose metabolism using 18F-fluorodeoxyglucose positron emission tomography and measurements of brain volume using magnetic resonance imaging in cognitively normal ε4 homozygotes, ε4 heterozygotes, and noncarriers. Academic medical center. A total of 31 ε4 homozygotes, 42 ε4 heterozygotes, and 76 noncarriers, 49 to 67 years old, matched for sex, age, and educational level. The measurements of posterior cingulate and hippocampal glucose metabolism were characterized using automated region-of-interest algorithms and normalized for whole-brain measurements. The hippocampal volume measurements were characterized using a semiautomated algorithm and normalized for total intracranial volume. Although there were no significant differences among the 3 groups of participants in their clinical ratings, neuropsychological test scores, hippocampal volumes (P = .60), or hippocampal glucose metabolism measurements (P = .12), there were significant group differences in their posterior cingulate glucose metabolism measurements (P = .001). The APOE ε4 gene dose was significantly associated with posterior cingulate glucose metabolism (r = 0.29, P = .0003), and this association was significantly greater than those with hippocampal volume or hippocampal glucose metabolism (P < .05, determined by use of pairwise Fisher z tests). Although our findings may depend in part on the analysis algorithms used, they suggest that a reduction in posterior cingulate glucose metabolism precedes a reduction in hippocampal volume or metabolism in cognitively normal persons at increased genetic risk for Alzheimer disease.